A citation-based method for searching scientific literature

Amany I Alqosaibi, Shaimaa Abdel-Ghany, Fatma Al-Mulhim, Hussein Sabit. Cancer Treat Res Commun 2022
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients.
J Remon, C E Steuer, S S Ramalingam, E Felip. Ann Oncol 2018
72
50

Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress.
Zhongliang Wang, Tingting Du, Xiaorong Dong, Zhenyu Li, Gang Wu, Ruiguang Zhang. Int J Oncol 2016
37
50

Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.
Li Li, Yubo Wang, Lin Jiao, Caiyu Lin, Conghua Lu, Kejun Zhang, Chen Hu, Junyi Ye, Dadong Zhang, Haiyan Wu,[...]. Cancer Lett 2019
41
50

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors.
D Westover, J Zugazagoitia, B C Cho, C M Lovly, L Paz-Ares. Ann Oncol 2018
265
50

Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line.
Zheng-Hai Tang, Xiao-Ming Jiang, Xia Guo, Chi Man Vivienne Fong, Xiuping Chen, Jin-Jian Lu. Oncotarget 2016
30
50

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities.
Rafael Rosell, Andrés Felipe Cardona, Oscar Arrieta, Andrés Aguilar, Masaoki Ito, Carlos Pedraz, Jordi Codony-Servat, Mariacarmela Santarpia. Br J Cancer 2021
7
50

Targeting Autophagy for Overcoming Resistance to Anti-EGFR Treatments.
Yoojung Kwon, Misun Kim, Hyun Suk Jung, Youngmi Kim, Dooil Jeoung. Cancers (Basel) 2019
41
50


EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
Hao Gong, Yongwen Li, Yin Yuan, Weiting Li, Hongbing Zhang, Zihe Zhang, Ruifeng Shi, Minghui Liu, Chao Liu, Chen Chen,[...]. BMC Cancer 2020
14
50

[Drug resistance mechanism of non small cell lung cancer PC9/AB2 cell line with acquired drug resistance to gefitinib].
Li-xia Ju, Cai-cun Zhou, Liang Tang, Yin-min Zhao, Xiao-jun Yang, Bo Su, Shu-yan Meng, Wei Li, Ling-hua Yan, Yong-mei Ding. Zhonghua Jie He He Hu Xi Za Zhi 2010
3
50


Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Yang Wang, Kairong Shi, Li Zhang, Guanlian Hu, Jingyu Wan, Jiajing Tang, Sheng Yin, Jiandong Duan, Ming Qin, Neng Wang,[...]. Autophagy 2016
42
50

Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTOR-dependent pathway.
Fu-Zheng Wei, Ziyang Cao, Xi Wang, Hui Wang, Mu-Yan Cai, Tingting Li, Naoko Hattori, Donglai Wang, Yipeng Du, Boyan Song,[...]. Autophagy 2015
95
50

Exon 16-Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M-Positive Non-Small Cell Lung Cancer.
Chia-Chi Hsu, Bin-Chi Liao, Wei-Yu Liao, Aleksandra Markovets, Daniel Stetson, Kenneth Thress, James Chih-Hsin Yang. J Thorac Oncol 2020
35
50

EZH2 regulates H2B phosphorylation and elevates colon cancer cell autophagy.
Zhongyuan Liu, Le Yang, Chongbai Zhong, Ling Zhou. J Cell Physiol 2020
15
50

Precision Management of Advanced Non-Small Cell Lung Cancer.
Ching-Yao Yang, James Chih-Hsin Yang, Pan-Chyr Yang. Annu Rev Med 2020
58
50

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
TaChung Yu, Fangfang Guo, Yanan Yu, Tiantian Sun, Dan Ma, Jixuan Han, Yun Qian, Ilona Kryczek, Danfeng Sun, Nisha Nagarsheth,[...]. Cell 2017
818
50


PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.
Junhu Wan, Jun Zhan, Shuai Li, Ji Ma, Weizhi Xu, Chang Liu, Xiaowei Xue, Yuping Xie, Weigang Fang, Y Eugene Chin,[...]. Nucleic Acids Res 2015
87
50

Targeting EZH2 in cancer.
Kimberly H Kim, Charles W M Roberts. Nat Med 2016
819
50


Lung cancer.
Alesha A Thai, Benjamin J Solomon, Lecia V Sequist, Justin F Gainor, Rebecca S Heist. Lancet 2021
243
50

The role of autophagy in pancreatic cancer progression.
Yuanyang Wang, Cheng Qin, Gang Yang, Bangbo Zhao, Weibin Wang. Biochim Biophys Acta Rev Cancer 2021
9
50


Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
Suresh S Ramalingam, Johan Vansteenkiste, David Planchard, Byoung Chul Cho, Jhanelle E Gray, Yuichiro Ohe, Caicun Zhou, Thanyanan Reungwetwattana, Ying Cheng, Busyamas Chewaskulyong,[...]. N Engl J Med 2020
962
50


Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance.
Charlotte E Johnson, Andrew R Tee. Essays Biochem 2017
22
50

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.
Tai-Lung Cha, Binhua P Zhou, Weiya Xia, Yadi Wu, Cheng-Chieh Yang, Chun-Te Chen, Bo Ping, Arie P Otte, Mien-Chie Hung. Science 2005
413
50

Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.
Qing Zhou, Xu-Chao Zhang, Zhi-Hong Chen, Xiao-Lu Yin, Jin-Ji Yang, Chong-Rui Xu, Hong-Hong Yan, Hua-Jun Chen, Jian Su, Wen-Zhao Zhong,[...]. J Clin Oncol 2011
193
50

Post-translational modifications of EZH2 in cancer.
Zhongwei Li, Minle Li, Diandian Wang, Pingfu Hou, Xintian Chen, Sufang Chu, Dafei Chai, Junnian Zheng, Jin Bai. Cell Biosci 2020
27
50

Third generation EGFR TKIs: current data and future directions.
Chee-Seng Tan, Nesaretnam Barr Kumarakulasinghe, Yi-Qing Huang, Yvonne Li En Ang, Joan Rou-En Choo, Boon-Cher Goh, Ross A Soo. Mol Cancer 2018
122
50

Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity.
Eileen White, Edmund C Lattime, Jessie Yanxiang Guo. Trends Cancer 2021
21
50

Expression profile of class I histone deacetylases in human cancer tissues.
Masamune Nakagawa, Yoshinao Oda, Takashi Eguchi, Shin-Ichi Aishima, Takashi Yao, Fumihito Hosoi, Yuji Basaki, Mayumi Ono, Michihiko Kuwano, Masao Tanaka,[...]. Oncol Rep 2007
248
50

The polycomb repressive complex 2 is a potential target of SUMO modifications.
Eva Madi Riising, Roberto Boggio, Susanna Chiocca, Kristian Helin, Diego Pasini. PLoS One 2008
43
50

Elevated and deregulated expression of HDAC3 in human astrocytic glial tumours.
P Libý, M Kostrouchová, M Pohludka, P Yilma, P Hrabal, J Sikora, E Brozová, M Kostrouchová, J E Rall, Z Kostrouch. Folia Biol (Praha) 2006
15
50

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives.
Robert Jenke, Nina Reßing, Finn K Hansen, Achim Aigner, Thomas Büch. Cancers (Basel) 2021
48
50

Gefitinib or Erlotinib vs Chemotherapy for EGFR Mutation-Positive Lung Cancer: Individual Patient Data Meta-Analysis of Overall Survival.
Chee Khoon Lee, Lucy Davies, Yi-Long Wu, Tetsuya Mitsudomi, Akira Inoue, Rafael Rosell, Caicun Zhou, Kazuhiko Nakagawa, Sumitra Thongprasert, Masahiro Fukuoka,[...]. J Natl Cancer Inst 2017
153
50

Identification of small proline-rich protein 1B (SPRR1B) as a prognostically predictive biomarker for lung adenocarcinoma by integrative bioinformatic analysis.
Zihe Zhang, Ruifeng Shi, Songlin Xu, Yongwen Li, Hongbing Zhang, Minghui Liu, Guangsheng Zhu, Chen Chen, Zhenhua Pan, Hongyu Liu,[...]. Thorac Cancer 2021
8
50

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita,[...]. N Engl J Med 2010
50

O-GlcNAcylation regulates the stability and enzymatic activity of the histone methyltransferase EZH2.
Pei-Wen Lo, Jiun-Jie Shie, Chein-Hung Chen, Chung-Yi Wu, Tsui-Ling Hsu, Chi-Huey Wong. Proc Natl Acad Sci U S A 2018
42
50

Autophagy and organelle homeostasis in cancer.
Dannah R Miller, Andrew Thorburn. Dev Cell 2021
27
50

Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery.
Takahiro Nagamoto, Yoshiyuki Hattori, Kozo Takayama, Yoshie Maitani. Pharm Res 2004
81
50

Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation.
Shaimaa Abdel-Ghany, Sara Raslan, Huseyin Tombuloglu, Aly Shamseddin, Emre Cevik, Osama A Said, Engy F Madyan, Mehmet Senel, Ayhan Bozkurt, Suriya Rehman,[...]. 3 Biotech 2020
10
50

In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Akhtar Rasul, Muhammad Imran Khan, Mujeeb Ur Rehman, Ghulam Abbas, Nosheen Aslam, Shabbir Ahmad, Khizar Abbas, Pervaiz Akhtar Shah, Muhammad Iqbal, Ali Mohammad Ahmed Al Subari,[...]. Int J Nanomedicine 2020
5
50

Transferrin-conjugated liposomes loaded with carnosic acid inhibit liver cancer growth by inducing mitochondria-mediated apoptosis.
Xin Liu, Shiyan Dong, Mingyuan Dong, Yuan Li, Zhen Sun, Xinrui Zhang, Yingwu Wang, Lesheng Teng, Di Wang. Int J Pharm 2021
4
50



Raging the War Against Inflammation With Natural Products.
Ali Attiq, Juriyati Jalil, Khairana Husain, Waqas Ahmad. Front Pharmacol 2018
70
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.